VOICED : Alemanas Bayer y CureVac unen sus fuerzas para desarrollar vacuna contra coronavirus

Bayer and CureVac have partnered to develop a COVID-19 vaccine. Bayer will assist in production and marketing. CureVac's vaccine, using mRNA technology, is in the final clinical trial phase and aims for market release this year. Unlike other vaccines, it remains stable at refrigerator temperatures, easing distribution. The European Commission has pre-ordered 405 million doses.

What new insight or understanding did you gain from this video?